Compare how Universal is using added balance sheet flexibility with a curated set of companies that also prioritize financial resilience through our 32 resilient stocks with low risk scores
To back Universal as a shareholder, you need to be comfortable with a business that still leans on tobacco while working to grow plant based ingredients. The near term story revolves around how it handles expected oversupply in flue cured and burley leaf and margin pressure in Ingredients, while interest cover and dividend sustainability stay under watch.
The amended credit covenant looks more like a safety valve than a game changer for the thesis. It may ease short term liquidity and timing risk around working capital, but it does not remove key operational swings, including weaker recent profit margins, tariff uncertainties, and the need to prove Ingredients can scale without eroding returns.
For this covenant change, the most relevant context is Universal reporting interest payments that are not well covered by earnings and a dividend yield of 8.39% that current profits do not comfortably fund. That combination makes any extra balance sheet headroom important to track, especially when there are higher risk funding sources and recent one off losses.
The relaxed leverage limit gives management a bit more time to work through tobacco oversupply, Ingredients mix issues, and cost absorption from past expansions. For you, the key watchpoints stay the same: interest coverage; how quickly margins in both segments stabilise; and whether future cash flow is strong enough to support both debt commitments and the payout without relying on accounting one offs.
Universal's narrative projects US$2.7b revenue and US$235.7m earnings by 2029. This assumes revenue declines by 1.3% per year and requires earnings to rise by about US$216.6m from US$19.1m today.
Uncover why Universal's fair value indicates a 69% potential upside to its current price, which could narrow quickly.
Two fair value estimates from the Simply Wall St Community span a wide band, from US$67 to about US$186.8 per share, so opinions on Universal diverge sharply. Those retail views were formed before the credit amendment and before fresh data on tobacco oversupply or Ingredients margin pressure. Use them as starting points and compare several alternative takes before deciding how Universal fits your portfolio.
Explore another Universal fair value estimate, including one that suggests potential upside of as much as 372% from the current price!
Disagree with existing narratives? Extraordinary investment outcomes rarely come from following the herd, so go with your instincts.
Universal may or may not fit your portfolio, so it can help to line it up against other opportunities that match your risk tolerance, dividend needs, or value focus. The Simply Wall St Screener lets you move from this single ticker to a broader watchlist in a few minutes.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com